Influenza Update for the 2020 – 2021 Flu Season

Published: March 2019
  Looking for subscriptions?
  • Key Points
  • Testing and Treatment of Influenza When SARS-CoV-2 and Influenza Viruses are Co-circulating
  • Prevention 
    • Chemoprophylaxis
  • Treatment 
    • Antiviral Dosing
    • Antiviral Treatment for Suspected or Confirmed Influenza
    • Bacterial Coinfection
    • Antiviral Failure
    • Antiviral-resistant Infection Testing
    • Adjunctive Therapy
  • Institutional Outbreak Control
  • Diagnosis
    • Testing
      • Outpatients (including emergency department patients)
      • Hospitalized Patients
    • Specimens
    • Diagnostic Tests* Tables
    • Influenza Vaccines — United States, 2020–21 Influenza Season
    • Contraindications and Precautions to the Use of
  • Influenza Vaccines — United States, 2020–21 Influenza Season
    • Dose Volumes for Inactivated Influenza Vaccines
  • Licensed for Children Aged 6 through 35 months— United States, 2020–21 Influenza Season
    • Antiviral Agents and Dosing Recommendations for
  • Treatment and Chemoprophylaxis of Influenza
    • Control Measures for Managing Institutional Influenza Outbreaks
    • Signs and Symptoms of Uncomplicated Influenza
    • Clinical Manifestations and Complications
  • Associated With Influenza
    • Persons Who Are at High Risk of Complications
  • From Influenza
    • Groups in Whom to Consider a Diagnosis of Influenza
    • Influenza Diagnostic Tests for Respiratory Specimens
    • Multiplex Assays Authorized for Simultaneous Detection of Influenza Viruses and SARS-CoV-2 by FDA Emergency Use Authorization  – List of Differential Diagnoses to Consider for Patients With Influenza Who Do Not Improve or Have Clinical Deterioration With Antiviral Treatment 
  • Figures
    • Influenza Vaccine Dosing Algorithm for Children Aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2020–21 Influenza Season
  • Algorithm
    • Guide for Considering Influenza Testing When Influenza Viruses are Circulating in the Community (regardless of influenza vaccination history)
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

Description

This pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.

Price:$11.95

Digital Download Information:
  • Supported on Apple and Android devices
  • Content is accessible offline
  • PDF Format
  • Download instantly from your account
Clear
Need help?